Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director, 10%+ Owner
-
Stock Symbol
-
SPRY on Nasdaq
Ra Capital Management, L.P. - trading volume in the past year for ARS Pharmaceuticals, Inc.
Holdings reported by Ra Capital Management, L.P. for ARS Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
9.96M |
$97.5M |
$9.79 |
Mar 27, 2024 |
Indirect |
|
|
Stock Option (Right to Buy) |
40K |
|
|
Jun 20, 2024 |
Indirect |
Common Stock |
|
Transactions reported by Ra Capital Management, L.P. for ARS Pharmaceuticals, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.